Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection

Clinical trial NCT07435649 · RECRUITING

Trial details

NCT number: NCT07435649
Sponsor: Delve Bio, Inc.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Central Nervous System Infection

Start date: 2026-05-01
Primary completion: 2027-06-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.